Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among CYP2C19 Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial.
Anxin WangXuewei XieXue TianS Claiborne JohnstonHao LiPhilip M BathYingting ZuoJing JingJinxi LinYilong WangXingquan ZhaoZixiao LiYong JiangLi-Ping LiuXia MengYongjun WangPublished in: Annals of internal medicine (2022)
Ministry of Science and Technology of the People's Republic of China.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- cerebral ischemia
- low dose
- atrial fibrillation
- cardiovascular events
- st segment elevation myocardial infarction
- study protocol
- public health
- st elevation myocardial infarction
- phase iii
- subarachnoid hemorrhage
- clinical trial
- coronary artery disease
- phase ii
- blood brain barrier
- ischemia reperfusion injury
- brain injury
- type diabetes
- cardiovascular disease
- randomized controlled trial
- oxidative stress
- open label